DK2170857T3 - 3',4',5-trimethoxyflavonderivater som stimulerende middel ved slimafsondring, tilsvarende fremgangsmåde og farmaceutisk præparat, der indeholder disse - Google Patents

3',4',5-trimethoxyflavonderivater som stimulerende middel ved slimafsondring, tilsvarende fremgangsmåde og farmaceutisk præparat, der indeholder disse

Info

Publication number: DK2170857T3
Authority: DK; Denmark
Prior art keywords: pharmaceutical composition; trimethoxyflavone; stimulants; derivatives; composition containing
Prior art date: 2007-06-07

Application number

DK08766040.3T

Other languages

English (en)

Inventor

Kyung-Koo Kang

Dong-Sung Kim

Jeong-Hoon Kim

Moo-Hi Yoo

Mi-Jeong Seo

Ju-Mi Kim

Yong-Duck Kim

Sun-Woo Jang

Yong-Sung Shon

Seul-Min Choi

Byoung-Ok Ahn

Original Assignee

Dong A Pharm Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-06-07

Filing date

2008-06-02

Publication date

2011-12-05

2008-06-02 Application filed by Dong A Pharm Co Ltd filed Critical Dong A Pharm Co Ltd

2011-12-05 Application granted granted Critical

2011-12-05 Publication of DK2170857T3 publication Critical patent/DK2170857T3/da

Links

IIOQEHSFZUYICM-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-methoxychromen-4-one Chemical class C1=C(OC)C(OC)=CC=C1C1=CC(=O)C2=C(OC)C=CC=C2O1 IIOQEHSFZUYICM-UHFFFAOYSA-N 0.000 title abstract 3
210000003097 mucus Anatomy 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title abstract 2
239000000021 stimulant Substances 0.000 title 1
208000003556 Dry Eye Syndromes Diseases 0.000 abstract 2
206010013774 Dry eye Diseases 0.000 abstract 2
150000003839 salts Chemical class 0.000 abstract 2
208000028006 Corneal injury Diseases 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
210000000795 conjunctiva Anatomy 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1
230000000069 prophylactic effect Effects 0.000 abstract 1
230000028327 secretion Effects 0.000 abstract 1
230000004936 stimulating effect Effects 0.000 abstract 1
229940124597 therapeutic agent Drugs 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
- C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Ophthalmology & Optometry (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyrane Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK08766040.3T 2007-06-07 2008-06-02 3',4',5-trimethoxyflavonderivater som stimulerende middel ved slimafsondring, tilsvarende fremgangsmåde og farmaceutisk præparat, der indeholder disse DK2170857T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
KR1020070055427A KR100930467B1 (ko)	2007-06-07	2007-06-07	점액분비를 촉진시키는 3',4',5-트리메톡시 플라본 유도체화합물, 그의 제조방법 및 약학적 용도
PCT/KR2008/003078 WO2008150085A2 (en)	2007-06-07	2008-06-02	3',4',5-trimethoxy flavone derivatives as stimulant of mucus secretion, method of the same, and pharmaceutical composition comprising the same

Publications (1)

Publication Number	Publication Date
DK2170857T3 true DK2170857T3 (da)	2011-12-05

Family

ID=40094296

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK08766040.3T DK2170857T3 (da)	2007-06-07	2008-06-02	3',4',5-trimethoxyflavonderivater som stimulerende middel ved slimafsondring, tilsvarende fremgangsmåde og farmaceutisk præparat, der indeholder disse

Country Status (14)

Country	Link
US (1)	US8203011B2 (da)
EP (1)	EP2170857B1 (da)
JP (1)	JP5295230B2 (da)
KR (1)	KR100930467B1 (da)
CN (1)	CN101679341B (da)
AT (1)	ATE529417T1 (da)
AU (1)	AU2008260829B2 (da)
BR (1)	BRPI0812494A2 (da)
CA (1)	CA2689136C (da)
DK (1)	DK2170857T3 (da)
ES (1)	ES2375184T3 (da)
MX (1)	MX2009013062A (da)
PT (1)	PT2170857E (da)
WO (1)	WO2008150085A2 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20090258939A1 (en) *	2007-07-31	2009-10-15	Wendye Robbins	Pyrone analog compositions and methods
EP2424541A2 (en) *	2009-04-27	2012-03-07	Limerick BioPharma, Inc.	Phosphorylated and phosphonated pyrone analogs for therapeutic treatment
CN102796066B (zh) *	2012-08-31	2014-09-03	云南民族大学	一种黄酮类化合物及其制备方法与应用
CN103059005B (zh) *	2012-11-22	2015-04-22	中南民族大学	白杨素酰胺衍生物及其医药用途
CN107921022B (zh) *	2015-08-24	2021-06-01	澳门大学	用于治疗干眼病和斯耶格伦氏综合征的组合物
CN107373745B (zh) *	2017-07-28	2020-04-03	云南中烟工业有限责任公司	一种防止烟草料液腐败变质的添加剂及其应用
KR102040810B1 (ko)	2018-01-31	2019-11-05	인제대학교 산학협력단	알파-휴물렌을 유효성분으로 함유하는 안구 건조증 예방 또는 치료용 조성물
KR102685191B1 (ko) *	2021-07-26	2024-07-15	동아제약 주식회사	레코플라본 또는 이의 염을 포함하는 피부개선용 화장료 조성물
US20250082603A1 (en)	2021-08-05	2025-03-13	Gl Pharmtech Corp.	Ophthalmic composition containing recoflavone for the treatment of dry eye disease and method for preparing the same
KR102356603B1 (ko) *	2021-08-05	2022-02-08	지엘팜텍주식회사	안구건조증 치료를 위한 레코플라본 함유 점안 조성물
EP4342453A4 (en) *	2021-08-05	2025-06-18	GL Pharmtech Corp.	Eye drop composition for treating dry eye syndrome containing recofflavone and method for producing the same

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA873745B (en) *	1986-06-04	1988-10-26	Daiichi Seiyaku Co	Benzopyran derivatives
DE3628590A1 (de) *	1986-08-22	1988-02-25	Musikon Gmbh	Raumeinheit fuer die aufnahme und/oder wiedergabe von akustischen signalen
US5006550A (en) *	1989-12-29	1991-04-09	Allergan, Inc.	Chroman esters of phenols and benzoic acids having retinoid-like activity
KR100447918B1 (ko) *	1996-07-25	2005-09-28	동아제약주식회사	대장을포함한위장관보호작용을갖는플라본및플라바논화합물
FR2753969B1 (fr) *	1996-09-27	1998-10-30	Adir	Nouveaux derives de flavones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP3957795B2 (ja) *	1996-10-04	2007-08-15	興和株式会社	フラボン誘導体及びこれを含有する医薬
JPH11279062A (ja) *	1998-01-30	1999-10-12	Fujisawa Pharmaceut Co Ltd	眼科用剤
KR100327621B1 (ko)	1999-09-22	2002-03-15	유충식	7-카르복시메틸옥시-3',4',5-트리메톡시플라본의 제조방법
JP2001233775A (ja) *	2000-02-28	2001-08-28	Cci Corp	涙液分泌促進剤
KR20050024121A (ko) *	2003-09-04	2005-03-10	동아제약주식회사	7-카르복시메틸옥시-3',4',5-트리메톡시 플라본.일수화물, 이의 제조방법 및 용도
NZ560633A (en)	2005-03-11	2011-08-26	Neuprotect Pty Ltd	Flavonoid compounds and uses thereof
US8168655B2 (en) *	2005-05-17	2012-05-01	Sarcode Bioscience Inc.	Compositions and methods for treatment of eye disorders

2007
- 2007-06-07 KR KR1020070055427A patent/KR100930467B1/ko active Active
2008
- 2008-06-02 AU AU2008260829A patent/AU2008260829B2/en not_active Ceased
- 2008-06-02 US US12/451,902 patent/US8203011B2/en not_active Expired - Fee Related
- 2008-06-02 WO PCT/KR2008/003078 patent/WO2008150085A2/en not_active Ceased
- 2008-06-02 CA CA2689136A patent/CA2689136C/en not_active Expired - Fee Related
- 2008-06-02 JP JP2010511105A patent/JP5295230B2/ja not_active Expired - Fee Related
- 2008-06-02 AT AT08766040T patent/ATE529417T1/de active
- 2008-06-02 DK DK08766040.3T patent/DK2170857T3/da active
- 2008-06-02 PT PT08766040T patent/PT2170857E/pt unknown
- 2008-06-02 CN CN2008800190634A patent/CN101679341B/zh not_active Expired - Fee Related
- 2008-06-02 BR BRPI0812494-9A patent/BRPI0812494A2/pt not_active IP Right Cessation
- 2008-06-02 ES ES08766040T patent/ES2375184T3/es active Active
- 2008-06-02 MX MX2009013062A patent/MX2009013062A/es active IP Right Grant
- 2008-06-02 EP EP08766040A patent/EP2170857B1/en active Active

Also Published As

Publication number	Publication date
EP2170857A4 (en)	2010-06-23
US20100130448A1 (en)	2010-05-27
EP2170857B1 (en)	2011-10-19
JP2010529112A (ja)	2010-08-26
AU2008260829A1 (en)	2008-12-11
CN101679341A (zh)	2010-03-24
ES2375184T3 (es)	2012-02-27
US8203011B2 (en)	2012-06-19
MX2009013062A (es)	2010-01-18
CA2689136A1 (en)	2008-12-11
JP5295230B2 (ja)	2013-09-18
KR20080107542A (ko)	2008-12-11
BRPI0812494A2 (pt)	2015-06-16
WO2008150085A3 (en)	2009-02-26
CN101679341B (zh)	2012-06-06
CA2689136C (en)	2012-11-13
KR100930467B1 (ko)	2009-12-08
ATE529417T1 (de)	2011-11-15
AU2008260829B2 (en)	2012-11-08
PT2170857E (pt)	2011-12-12
WO2008150085A2 (en)	2008-12-11
EP2170857A2 (en)	2010-04-07

Publication	Publication Date	Title
MX2009013062A (es)	2010-01-18	Derivados de 3´4´,5-trimetoxi flavona como estimulante de secrecion de mucosa, metodo de los mismos, y composicion farmaceutica que comprende los mismos.
NO20025601D0 (no)	2002-11-21	Arylmetylaminderivater for anvendelse som tryptaseinhibitorer
MX2020001403A (es)	2020-03-09	Nuevos derivados de quinolina.
NO20081550L (no)	2008-05-28	Preventivt eller terapeutisk middel for sykdom forarsaket av minskning i lakrimalvaeske
NO20075660L (no)	2008-02-22	Blanding for behandling av inflammatoriske sykdommer
MX2017010287A (es)	2018-02-09	Composiciones farmaceuticas que comprenden n-(3,5-dimetoxifenil)-n '-(1-metiletil)-n-[3-(1-metil-1h-pirazol-4-il)quinoxalin-6-il]eta no-1,2-diamina.
NO20082643L (no)	2008-09-01	Isokinolinaminopyrazolderivater, deres fremstilling og anvendelse som farmasoytiske midler for behandling av kreft
ZA200709251B (en)	2009-08-26	Suspension formulations comprising an active principle, a poloxamer or meroxapol surfactant and a glycol, its use for the manufacture of a medicament for treating ophthalmic disorders
CY1108676T1 (el)	2014-04-09	Οφθαλμικο εναιωρημα περιλαμβανον ενα οφθαλμικο φαρμακο, μια πολοξαμινη και εναν παραγοντα ρυθμισεως της τονικοτητας τυπου γλυκολης, χρηση της εν λογω συνθεσεως για την παραγωγη ενος φαρμακου για την αγωγη οφθαλμικων διαταραχων
UA92000C2 (en)	2010-09-27	1-benzylindole-2-carboxamide derivatives
WO2007127333A3 (en)	2008-08-07	Compositions for the treatment and prevention of eyelid swelling
MX2010005012A (es)	2010-06-23	Composiciones para el tratamieno y prevencion de inflamacion de los parpados que comprenden un ingrediente osmoticamente activo y un vasocosntrictor.
DK1296972T3 (da)	2010-04-26	Arylmethylamin-derivater til anvendelse som tryptaseinhibitorer
PH12016501357B1 (en)	2020-12-09	Pharmaceutical preparation containing pyridylaminoacetic acid compound
NO20074850L (no)	2007-09-24	Oftalmologiske sammensetninger og anvendelse derav
AR063538A1 (es)	2009-01-28	Tratamiento de la enfermedad de parkinson
BRPI0510778B8 (pt)	2021-05-25	composição farmacêutica, processo para preparação da :mesma, e, uso de uma composição
MX2009005798A (es)	2009-08-12	Recuperacion de apoplejia.
NO20092763L (no)	2009-07-27	Isosorbid mononitrat derivater for behandling av tarmlidelser
EP1915998A8 (en)	2008-10-01	Prophylactic or therapeutic agent for corneal/conjunctival disease
WO2008004100A9 (en)	2012-04-19	Therapeutic compounds
NO20074661L (no)	2007-10-30	Anvendelse av en forbindelse
NO20090193L (no)	2009-01-29	Substituerte heterocykliske etere og anvendelse derav i CNS forstyrrelser
WO2019004788A3 (ko)	2019-02-28	브라우쏘칼콘 a를 유효성분으로 포함하는 염증성 장질환 예방 또는 치료용 약학 조성물
WO2007023072A3 (en)	2007-05-03	Use of ambroxol for the treatment of rhinovirus infections